Skip to content
Thursday, July 16, 2026

Ayen News

Democratizing information: Free world-class API and RSS feeds for every business.

  • Business
  • National
  • International
  • Crime
  • Technology & AI
  • Health & Science
  • Legal
  • Sports
  • Fact Check
  • Blog

Tag: semaglutide

  • Home
  • semaglutide
  • Health & Science

GLP-1 Drugs Like Ozempic Are Opening the Door to a New Era of Obesity Treatment — Expert Review

  • June 29, 2026
  • 0

A comprehensive review says the success of semaglutide and tirzepatide is not just about weight loss but signals a paradigm shift in how metabolic disease is approached.

  • Health & Science

Semaglutide Ozempic Linked to Fewer Bone Fractures Despite Greater Weight Loss Than Other Interventions

  • June 26, 2026
  • 0

GLP-1 receptor agonist drugs appear to have bone-protective effects potentially through preservation of lean muscle mass during weight loss.

  • Health & Science

Semaglutide Linked to 15 Percent Lower Fracture Risk Alongside Greater Weight Loss Says Study

  • June 19, 2026
  • 0

A major new study found that semaglutide the active ingredient in Ozempic and Wegovy is linked to a 15 percent lower risk of bone fractures as well as greater weight loss.

  • Health & Science

Semaglutide Linked to 15% Decrease in Bone Fractures Compared to Other Weight-Loss Drugs

  • June 16, 2026
  • 0

New research shows semaglutide not only leads to greater weight loss but also significantly reduces the risk of bone fractures in treated patients.

  • Health & Science

GLP-1 Weight Loss Drugs Linked to Lower Risk of Addiction and Overdose in Veteran Study

  • June 6, 2026
  • 0

A study of over 600000 US veterans found semaglutide and similar GLP-1 drugs reduced the likelihood of developing substance use disorders across multiple addictions.

  • Health & Science

GLP-1 Drugs Like Semaglutide Linked to 30 Percent Lower Breast Cancer Risk in Obese Women

  • June 6, 2026
  • 0

Large retrospective study suggests GLP-1 drug use among obese women could significantly reduce the risk of developing breast cancer

  • Health & Science

Wegovy Carries Highest Risk of Rare Eye Stroke That Can Cause Sudden Vision Loss

  • May 26, 2026
  • 0

A study based on millions of FDA side-effect reports identified a troubling ocular risk linked to the weight-loss drug.

  • Health & Science

New NIH Research Reveals Why GLP-1 Drugs Like Semaglutide Work Differently in Different People

  • May 26, 2026
  • 0

Scientists found semaglutide sparks different responses in appetite-controlling brain cells across individuals.

  • Health & Science

AI Scans 400000 Reddit Posts and Finds Hidden Ozempic Side Effects Including Menstrual Irregularities

  • May 26, 2026
  • 0

The study suggests AI could transform pharmacovigilance by detecting adverse effects from patient-generated data.

  • Blog

The GLP-1 Drug Debate: Are We Overprescribing Weight-Loss Injections?

  • May 26, 2026
  • 0

A personal account and opinion piece on how semaglutide is reshaping diet culture.

Recent Posts

  • California’s Claude discount deal called the largest state AI deployment in US history
  • Edge226 acquires AnyClip to strengthen AI-powered video marketing
  • QuadSci named Machine Learning Company of the Year
  • Profound launches ‘Aim,’ an always-on AI marketing intelligence agent
  • Cursor discounts Composer 2.5 usage by 75% through July 5

Recent Comments

No comments to show.

Archives

  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026

Categories

  • Blog
  • Business
  • Crime
  • Fact Check
  • Health & Science
  • International
  • Legal
  • National
  • Sports
  • Technology & AI

Important Links

News Disclaimer | RSS Feeds | Learn more about Ayen

Copyright © 2026 Ayen News - Click here for API access. Theme: Gateway News By Adore Themes.